BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 21515099)

  • 1. Characteristics of autoimmune pancreatitis based on serum IgG4 level.
    Matsubayashi H; Sawai H; Kimura H; Yamaguchi Y; Tanaka M; Kakushima N; Takizawa K; Kadooka M; Takao T; Hebbar S; Ono H
    Dig Liver Dis; 2011 Sep; 43(9):731-5. PubMed ID: 21515099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
    Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis.
    Takuma K; Kamisawa T; Igarashi Y
    Curr Opin Rheumatol; 2011 Jan; 23(1):80-7. PubMed ID: 21124090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
    Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
    Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune pancreatitis].
    Igaz P; Tulassay Z
    Orv Hetil; 2008 May; 149(19):873-6. PubMed ID: 18450546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative Rise of Serum IgG4 Levels After Steroid Therapy for Autoimmune Pancreatitis Predicts the Likelihood of Relapse.
    Suzuki D; Shimizu K; Tokushige K
    Pancreas; 2018 Apr; 47(4):412-417. PubMed ID: 29517627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis.
    Crosara S; D'Onofrio M; De Robertis R; Demozzi E; Canestrini S; Zamboni G; Pozzi Mucelli R
    World J Gastroenterol; 2014 Dec; 20(45):16881-90. PubMed ID: 25493001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin G4-related autoimmune pancreatitis and sialadenitis: A case report.
    Fan RY; Sheng JQ
    World J Gastroenterol; 2015 Aug; 21(31):9448-52. PubMed ID: 26309373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble IL-2 receptor, a new marker for autoimmune pancreatitis.
    Matsubayashi H; Uesaka K; Kanemoto H; Asakura K; Kakushima N; Tanaka M; Kimura H; Ono H
    Pancreas; 2012 Apr; 41(3):493-6. PubMed ID: 22415671
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
    Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Zhang L; Clain JE; Pearson RK; Petersen BT; Vege SS; Farnell MB
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1010-6; quiz 934. PubMed ID: 16843735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis.
    Talar-Wojnarowska R; Gąsiorowska A; Olakowski M; Dranka-Bojarowska D; Lampe P; Śmigielski J; Kujawiak M; Grzegorczyk J; Małecka-Panas E
    Adv Med Sci; 2014 Sep; 59(2):288-92. PubMed ID: 25194335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmune pancreatitis with normal IgG4-Levels: 4 case reports and review of the literature].
    Pace A; Topalidis T; Bläker M; Guthoff A; de Weerth A; Lohse AW
    Z Gastroenterol; 2007 Dec; 45(12):1245-51. PubMed ID: 18080226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune pancreatitis: updated concepts of a challenging diagnosis.
    Morse B; Centeno B; Vignesh S
    Am J Med; 2014 Oct; 127(10):1010.e1-9. PubMed ID: 24835039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis.
    Morselli-Labate AM; Pezzilli R
    J Gastroenterol Hepatol; 2009 Jan; 24(1):15-36. PubMed ID: 19067780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations.
    Vlachou PA; Khalili K; Jang HJ; Fischer S; Hirschfield GM; Kim TK
    Radiographics; 2011; 31(5):1379-402. PubMed ID: 21918050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune pancreatitis.
    Ketikoglou I; Moulakakis A
    Dig Liver Dis; 2005 Mar; 37(3):211-5. PubMed ID: 15888288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis.
    Matsubayashi H; Furukawa H; Maeda A; Matsunaga K; Kanemoto H; Uesaka K; Fukutomi A; Ono H
    Pancreatology; 2009; 9(5):694-9. PubMed ID: 19684434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IgG4-negative autoimmune pancreatitis.
    Kamisawa T; Takuma K; Tabata T; Inaba Y; Egawa N; Tsuruta K; Hishima T; Sasaki T; Itoi T
    J Gastroenterol; 2011 Jan; 46(1):108-16. PubMed ID: 20824290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics, recurrence features, and treatment outcomes of 55 patients with autoimmune pancreatitis].
    Park SJ; Kim MH; Moon SH; Han JH; Park DH; Lee SS; Seo DW; Lee SK
    Korean J Gastroenterol; 2008 Oct; 52(4):230-46. PubMed ID: 19077525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.